Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pituitary Neoplasms × DNA Methylation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Prolactinoma 1 Pituitary Neoplasms 1 Growth Hormone-Secreting Pituitary Adenoma 1 Central Nervous System Neoplasms 1 Adenoma, Chromophobe 1 Adenoma, Basophil 1 Adenoma, Acidophil 1

Interventions

lutetium Lu 177 dotatate 1 farletuzumab 1 Temozolomide 1 Microarray Analysis 1 DNA Methylation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00601289 2020-07-31

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Jonsson Comprehensive Cancer Center

Phase 2 Withdrawn

Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Pituitary Neoplasms, Prolactinoma, Central Nervous System Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡